Patents by Inventor Scott Caldwell

Scott Caldwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
    Patent number: 5861423
    Abstract: Patients susceptible to or suffering from central nervous system disorders (e.g., Alzheimer's disease, Parkinson's disease, Tourette's syndrome, attention deficit disorder or schizophrenia) are treated by administering an effective amount of an aryl substituted olefinic amine compound. Exemplary compounds include (E)-N-methyl-4-?3-(5-benzyloxypyridin)yl!-3-buten-1-amine, (E)-N-methyl-4-?3-(5-phenoxypyridin)yl!-3-buten-1-amine, and (E)-N-methyl-4-?3-(5-phenylpyridin)yl!-3-buten-1-amine.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: January 19, 1999
    Inventors: William Scott Caldwell, Gary Maurice Dull, Merouane Bencherif, Patrick Michael Lippiello
  • Pharmaceutical compositions for prevention and treatment of central nervous system disorders
    Patent number: 5824692
    Abstract: Patients susceptible to or suffering from central nervous system disorders (e.g., neurodegenerative diseases including presenile dementia, senile dementia of the Alzeimer's type, and Parkinsonism including Parkinson's disease) are treated by administering an effective amount of an aryl substituted aliphatic compound, an aryl substituted olefinic amine compound or an aryl substituted acetylenic compound. Exemplary compounds are (E)-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-4-?3-(5-methoxypyridin)yl!-3-butene-1-amine, (E)-N-methyl-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-N-methyl-4-?3-(5-methoxypyrindin)yl!-3-butene-1-amine, (Z)-metanicotine, N-methyl-(3-pyridinyl)-butane-1-amine, N-methyl-4-(3-pyridinyl)-3-butyne-1-amine and (E)-N-methyl-4-?3-(6-methylpyrindin)yl!-3-butene-1-amine.
    Type: Grant
    Filed: January 6, 1995
    Date of Patent: October 20, 1998
    Inventors: Patrick Michael Lippiello, Merouane Bencherif, William Scott Caldwell, Gary Maurice Dull
  • Pharamceutical compositions for prevention and treatment of tourette's syndrome
    Patent number: 5731314
    Abstract: Patients susceptible to or suffering from Tourette's syndrome are treated by administering an effective amount of an aryl substituted aliphatic compound, an aryl substituted olefinic amine compound or an aryl substituted acetylenic compound. Exemplary compounds are (E)-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-4-?3-(5-methoxypyridin)yl!-3-butene-1-amine, (E)-N-methyl-4-(5-pyrimidinyl)-3-butene-1-amine, (E)-N-methyl-4-?3-(5-methoxypyrindin)yl!-3-butene-1-amine, (Z)-metanicotine, (E)-metanicotine, N-methyl-(3-pyridinyl)-butane-1-amine, N-methyl-4-(3-pyridinyl)-3-butyne-1-amine and (E)-N-methyl-4-?3-(6-methylpyrindin)yl!-3-butene-1-amine.
    Type: Grant
    Filed: January 6, 1995
    Date of Patent: March 24, 1998
    Inventors: Merouane Bencherif, Patrick Michael Lippiello, William Scott Caldwell, Gary Maurice Dull
  • Pharmaceutical compositions for prevention and treatment of central nervous system disorders
    Patent number: 5726316
    Abstract: Patients susceptible to or suffering from central nervous system disorders are treated by administering an effective amount of an aryl substituted olefinic amine compound or an aryl substituted acetylenic compound. Exemplary compounds are (E)-N-methyl-4-?3-(6-methylpyrindin)yl!-3-butene-1-amine and N-methyl-4-(3-pyridinyl)-3-butyne-1-amine.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: March 10, 1998
    Inventors: Peter Anthony Crooks, William Scott Caldwell, Gary Maurice Dull, Balwinder Singh Bhatti, Niranjan Madhukar Deo, Alain Ravard